← Back to Search

Dietary Supplement

Synaquell for Brain Function in Athletes

N/A
Waitlist Available
Led By Michael Stuart, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, postseason (approximately 6 months)
Awards & highlights

Study Summary

This trial is testing if a dietary supplement can improve brain function in young hockey players.

Who is the study for?
This trial is for medically cleared youth ice hockey players who speak English fluently. It's not suitable for those with pacemakers, defibrillators, in-ear hearing devices, skull implants, seizure history or allergies to SynaquellTM ingredients, rubbing alcohol or EEG gel.Check my eligibility
What is being tested?
The study tests the effects of a dietary supplement called Synaquell(TM) on brain function in these athletes. Participants will either receive Synaquell(TM) or a placebo without knowing which one they are taking.See study design
What are the potential side effects?
Potential side effects aren't specified but may relate to individual sensitivity to the ingredients of Synaquell(TM) or the placebo used in this research.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, postseason (approximately 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, postseason (approximately 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in N100 Amplitude
Change in N100 Latency
Change in N400 Amplitude
+4 more
Secondary outcome measures
Change in King-Devick Test (KDT) scores

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Synaquell Male GroupExperimental Treatment1 Intervention
Male youth hockey players will receive the dietary supplement Synaquell, twice-daily during the hockey season. Due to difference in game rules and playing styles, males and females will be treated as two separate arms of the research protocol.
Group II: Synaquell Female GroupExperimental Treatment1 Intervention
Female youth hockey players will receive the dietary supplement Synaquell, twice-daily during the hockey season. Due to difference in game rules and playing styles, males and females will be treated as two separate arms of the research protocol.
Group III: Placebo Male GroupPlacebo Group1 Intervention
Male youth hockey players will receive the placebo twice-daily, during the hockey season. Due to difference in game rules and playing styles, males and females will be treated as two separate arms of the research protocol.
Group IV: Placebo Female GroupPlacebo Group1 Intervention
Female youth hockey players will receive the placebo twice-daily, during the hockey season. Due to difference in game rules and playing styles, males and females will be treated as two separate arms of the research protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Synaquell
2021
N/A
~140

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,175 Previous Clinical Trials
3,758,080 Total Patients Enrolled
Michael Stuart, MDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
4,100 Total Patients Enrolled

Media Library

Placebo (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05498818 — N/A
Healthy Subjects Research Study Groups: Placebo Male Group, Synaquell Male Group, Synaquell Female Group, Placebo Female Group
Healthy Subjects Clinical Trial 2023: Placebo Highlights & Side Effects. Trial Name: NCT05498818 — N/A
Placebo (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05498818 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what degree has recruitment been successful for this experiment?

"Indeed, the information from clinicaltrials.gov attests that this trial is actively recruiting individuals. It was first published on November 3rd 2022 and last modified on November 23rd of the same year. 150 volunteers will be welcome at one single site."

Answered by AI

Is the research team actively looking for new participants?

"Affirmative, the information hosted on clinicaltrials.gov illustrates that this trial is in ongoing recruitment mode. The experiment was launched on November 3rd 2022 and saw its most recent update posted by November 23rd of the same year. A cohort size of 150 participants needs to be recruited from a single medical facility."

Answered by AI

Does this clinical trial accommodate individuals below the age of thirty?

"This clinical trial accepts patients aged between 13 and 19, in keeping with the predetermined inclusion criteria."

Answered by AI

Would I be eligible to partake in this investigation?

"To be accepted to this experiment, adolescent candidates aged between 13 and 19 with healthy subject (HS) status must apply. The total sample size for the trial is slated at 150 participants."

Answered by AI
~35 spots leftby Mar 2025